• Clinical Trials
  • Contact Us
  • Careers
  • Our Motivation
      • Patient Stories
        • Bailey
        • Kendra
        • Sheri
        • Matty
      • Diseases & Conditions
        • PKU
        • CLN2 Disease
        • MPS VI
        • MPS IVA
        • MPS I
      • Patient & Community Support
        • RARE Scholars
        • In the Hemophilia Community
        • Patient Advocacy
        • BioMarin RareConnections™
        • Funding & Support
      • Resource Library
        • Patient Organizations
        • Professional Organizations
    • Our Treatments
        • Our Products
          • PALYNZIQ® (pegvaliase-pqpz) Injection for PKU
          • Brineura® (cerliponase alfa) for CLN2 Disease
          • Vimizim® (elosulfase alfa) for Morquio A Syndrome (MPS IVA)
          • Kuvan® (sapropterin dihydrochloride) for PKU
          • Aldurazyme® (laronidase) for MPS I
          • Naglazyme® (galsulfase) for MPS VI
        • Our Pipeline
          • Valoctocogene Roxaparvovec for Severe Hemophilia A
          • Vosoritide for Achondroplasia
          • BMN 307 for Phenylketonuria (PKU)
          • BMN 331 for Hereditary Angiodema (HAE)
      • Our Company
          • About Us
            • Our History
            • Manufacturing Excellence
            • Message from Chairman and CEO
            • Diversity & Inclusion
            • Global Compliance & Ethics
          • Corporate Global Responsibility
          • Leadership Team
            • Jean-Jacques Bienaimé
            • Robert A. Baffi, Ph.D.
            • Henry J. Fuchs, M.D.
            • Jeff Ajer
            • G. Eric Davis
            • Dr. C. Greg Guyer Ph.D.
            • Amy Wireman
            • Dr. Brinda Balakrishnan, M.D., Ph.D.
            • Lon Cardon, Ph.D.
            • Brian R. Mueller
          • Board of Directors
          • Funding & Support
            • Grants & Donations
            • Publication Data Request
            • Independent Medical Education
            • Independent Research
        • Investors & Media
            • Welcome to BioMarin's Investor Relations & Media Page
            • Press Releases
            • Events & Presentations
            • Corporate Governance
              • Management
              • Board of Directors
              • Committee Composition
              • Contact the Board
            • Financial Information
              • SEC Filings
              • Annual Reports
              • Quarterly Results
              • IR Key Ratios
              • Financial Statements
              • BioMarin UK Tax Strategy
            • Analyst Coverage
            • Stock Information
              • Historical Stock Lookup
            • Investor FAQs
            • Contact Us
            • Email Alerts
          Search
          Search
          • Our Motivation
            • Patient Stories
            • Diseases & Conditions
            • Patient & Community Support
            • Resources
          • Our Treatments
            • Our Products
              • PALYNZIQ® (pegvaliase-pqpz) Injection for PKU
              • Kuvan® (sapropterin dihydrochloride) for PKU
              • Brineura® (cerliponase alfa) for CLN2 Disease
              • Aldurazyme® (laronidase) for MPS I
              • Vimizim® (elosulfase alfa) for Morquio A Syndrome (MPS IVA)
              • Naglazyme® (galsulfase) for MPS VI
            • Our Pipeline
              • BMN 307 for Phenylketonuria (PKU)
              • BMN 331 for Hereditary Angiodema (HAE)
              • Valoctocogene Roxaparvovec for Severe Hemophilia A
              • Vosoritide for Achondroplasia
            • Compassionate Use Policy
          • Our Company
            • About Us
            • Corporate Global Responsibility
            • Leadership Team
            • Board of Directors
            • Funding & Support
          • Investors & Media
            • Welcome to BioMarin's Investor Relations & Media Page
            • Press Releases
            • Events & Presentations
            • Corporate Governance
              • Management
              • Board of Directors
              • Committee Composition
              • Contact the Board
            • Financial Information
              • SEC Filings
              • Annual Reports
              • Quarterly Results
              • IR Key Ratios
              • Financial Statements
              • BioMarin UK Tax Strategy
            • Analyst Coverage
            • Stock Information
              • Historical Stock Lookup
            • Investor FAQs
            • Contact Us
            • Email Alerts
          • Privacy Policy
          • LinkedIn
          • Terms of Use
          • Facebook
          • Site Map
          • Instagram
          • Supplier Information
          • YouTube
          • Glossary

          © 2020 BioMarin. All rights reserved.

          Investors

          Image: BioMarin logo
          Our Company
          • About Us
            • Our History
            • Message from Chairman and CEO
            • Manufacturing Excellence
            • Diversity & Inclusion
            • Global Compliance & Ethics
          • Corporate Global Responsibility
          • Leadership Team
            • Jean-Jacques Bienaimé
            • Robert A. Baffi, Ph.D.
            • Henry J. Fuchs, M.D.
            • Jeff Ajer
            • G. Eric Davis
            • Philip Lo Scalzo
            • Amy Wireman
            • Dr. Brinda Balakrishnan, M.D., Ph.D.
            • Lon Cardon, Ph.D.
            • Brian R. Mueller
            • Dr. C. Greg Guyer Ph.D.
          • Board of Directors
          • Funding & Support
            • Grants & Donations
            • Publication Data Request
            • Independent Medical Education
            • Independent Research
          Search
          NASDAQBMRN
          YearTrailing 12-MonthsCalendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011Calendar Year 2010Calendar Year 2009Calendar Year 2008Calendar Year 2007Calendar Year 2006Calendar Year 2005Calendar Year 2004Calendar Year 2003Calendar Year 2002Calendar Year 2001Calendar Year 2000Calendar Year 1999
          ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
          FormDescriptionDateFormat
          10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 27, 2008Open Annual report which provides a comprehensive overview of the company for the past year in HTML.Open Annual report which provides a comprehensive overview of the company for the past year in DOC file.Open Annual report which provides a comprehensive overview of the company for the past year in PDF file.Open Annual report which provides a comprehensive overview of the company for the past year in XLS file.

          Investors/Media

          • Welcome to BioMarin's Investor Relations & Media Page
          • Press Releases
          • Events & Presentations
          • Corporate Governance
          • Financial Information
            • SEC Filings
            • Annual Reports
            • Quarterly Results
            • IR Key Ratios
            • Financial Statements
            • BioMarin UK Tax Strategy
          • Analyst Coverage
          • Stock Information
          • Investor FAQs
          • Contact Us
          • Email Alerts
          BioMarin Compliance & Ethics Hotline

          Compliance is our responsibility 
          Click here to file a report

          Image: BioMarin logo
          • Navigate
          • Our Motivation
          • Our Treatments
          • Our Company
          • Investors & Media
          • About
          • Our History
          • Our Products
          • Our Pipeline
          • Leadership Team
          • Board of Directors
          • Diversity & Inclusion
          • Contact
          • Global Contact Information
          • Our Locations
          • Report a Product Complaint
          • Report Adverse Event
          • Publication Data Request
          • Funding & Support
          • Connect
          • Careers
          • LinkedIn
          • Facebook
          • Instagram
          • YouTube

          © 2020 BioMarin. All rights reserved.

          • Privacy Policy
          • Terms of Use
          • Site Map
          • Supplier Information
          • Slavery Act Statement
          • Glossary
          • Contact Us
          This website uses cookies to improve website functionality. You may delete or block cookies by accessing your preferences. For more information, please see our Privacy Policy and Terms and Conditions. By using this website, you consent to our use of cookies.Accept